I wouldn't put it past the carter team to simply file 1 expert report after another that simply up the price by a fraction of a margin to further solidify the case (affirming/validating a previous post inferring this is all a "game of winning" with lawyers) I tried to scrutinize Teece versus Tyler's background for variables/differences but they are both WELL ESTABLISHED with various arenas of proficiency
what stood out re: Tyler's CV for PTC was ~ "competition economics" & "the relationship between price and speed using regression analyses"..these assertions inevitably will be the bottom line to what our PPS will be worth when all is said & done
re: previous post ~ b4 someone points out the word "biosimilar" ..feel free to amend to "similar" for our IT status infringement re: Intellectual Property and Damages Reasonable royalty for patent infringement involving manufacturing process and method of treatment for a biosimilar product